(Q37765569)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Eva Tiensuu Janson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Halfdan Sørbye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Staffan Welin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Birgitte Federspiel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Henning Grønbaek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Per Hellman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Oystein Mathisen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Anders Sundin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Espen Thiis-Evensen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Matti J Välimäki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Kjell Oberg

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ulrich Knigge

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

740-756

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Biochemistry of neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: radiological examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Multidetector computed tomography and neuroendocrine pancreaticoduodenal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Medical management of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Neuroendocrine tumors. Biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Peptide-receptor radionuclide therapy for endocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Molecular genetics of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Carney complex: pathology and molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment of ECL cell carcinoids with octreotide LAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal o

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Well-differentiated pancreatic tumor/carcinoma: insulinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Malignancies of the appendix: beyond case series reports

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Small-cell carcinomas of the gastrointestinal tract: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

The surgical management of pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0284186X.2010.492791

10.3109/0284186X.2010.492791

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20553100%20AND%20SRC:MED&resulttype=core&format=json

release_lczjsexlsbh4jmsakmeyhpzawm

5 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lczjsexlsbh4jmsakmeyhpzawm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference